Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Stephen Bertram Soumerai, Sc.D.

Co-Author

This page shows the publications co-authored by Stephen Soumerai and Sebastian Schneeweiss.
Connection Strength

1.122
  1. Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. N Engl J Med. 2002 Mar 14; 346(11):822-9.
    View in: PubMed
    Score: 0.248
  2. Prescription duration after drug copay changes in older people: methodological aspects. J Am Geriatr Soc. 2002 Mar; 50(3):521-5.
    View in: PubMed
    Score: 0.247
  3. On the evaluation of drug benefits policy changes with longitudinal claims data: the policy maker's versus the clinician's perspective. Health Policy. 2001 Feb; 55(2):97-109.
    View in: PubMed
    Score: 0.230
  4. Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents. Med Care. 2004 Jul; 42(7):653-60.
    View in: PubMed
    Score: 0.073
  5. Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers. Clin Pharmacol Ther. 2003 Oct; 74(4):388-400.
    View in: PubMed
    Score: 0.069
  6. Physician gender and changes in drug prescribing after the implementation of reference pricing in British Columbia. Clin Ther. 2003 Jan; 25(1):273-84.
    View in: PubMed
    Score: 0.066
  7. Quasi-experimental longitudinal designs to evaluate drug benefit policy changes with low policy compliance. J Clin Epidemiol. 2002 Aug; 55(8):833-41.
    View in: PubMed
    Score: 0.064
  8. Reference drug pricing. CMAJ. 2002 Jul 23; 167(2):126-7; author reply 127-8.
    View in: PubMed
    Score: 0.064
  9. Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization. CMAJ. 2002 Mar 19; 166(6):737-45.
    View in: PubMed
    Score: 0.062
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.